These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14563516)

  • 41. Towards Developing a Scoring System for Febrile Thrombocytopenia.
    Kshirsagar P; Chauhan S; Samel D
    J Assoc Physicians India; 2016 Feb; 64(2):14-18. PubMed ID: 27730775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A consistent approach to platelet transfusion in the NICU.
    Del Vecchio A; Motta M; Radicioni M; Christensen RD
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura.
    Chandra J; Ravi R; Singh V; Narayan S; Sharma S; Dutta AK
    Hematology; 2006 Apr; 11(2):131-3. PubMed ID: 16753855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of platelet transfusion.
    McCullough J
    Semin Hematol; 2010 Jul; 47(3):235-42. PubMed ID: 20620434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of thrombocytopenia in cancer.
    Castaman G; Pieri L
    Thromb Res; 2018 Apr; 164 Suppl 1():S89-S93. PubMed ID: 29703490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.
    Gmür J; Burger J; Schanz U; Fehr J; Schaffner A
    Lancet; 1991 Nov; 338(8777):1223-6. PubMed ID: 1682642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome.
    Strauss R; Wehler M; Mehler K; Kreutzer D; Koebnick C; Hahn EG
    Crit Care Med; 2002 Aug; 30(8):1765-71. PubMed ID: 12163790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
    Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
    Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
    Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications?
    Roberts WE; Perry KG; Woods JB; Files JC; Blake PG; Martin JN
    Am J Obstet Gynecol; 1994 Sep; 171(3):799-804. PubMed ID: 8092232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical practice of platelet transfusions in haemato-oncology.
    Kreuger AL; Middelburg RA; Zwaginga JJ; van der Bom JG; Kerkhoffs JL
    Vox Sang; 2015 Jul; 109(1):91-4. PubMed ID: 25833739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients.
    Vinholt PJ; Hvas AM; Nybo M
    Eur J Haematol; 2014; 92(5):367-76. PubMed ID: 24400878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombocytopenia and platelet transfusions in patients with cancer.
    Valent J; Schiffer CA
    Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
    Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
    Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.